We Are Healthy

Wichita Falls Team Targets Protein Clumping in Alzheimer's

Early-stage NIH-funded research explores plant-derived proteins that may help prevent the buildup linked to Parkinson's and Alzheimer's.

Updated on Nov. 6, 2026 in Alzheimer’s

Clean laboratory bench with a rack of clear glass vials holding pale amber liquid and a pipette resting on stainless steel, under soft window daylight.
Midwestern State University professor Fu-Cheng George Liang received a $534,620 National Institutes of Health grant to study plant-derived proteins that may prevent protein clumping linked to Parkinson's and Alzheimer's. AI Illustration. Upload story photo >

Live Poll

Should the federal government spend more on research into Parkinson's and Alzheimer's?

Midwestern State University Texas professor Fu-Cheng "George" Liang has been awarded a $534,620 National Institutes of Health grant to study how plant-derived proteins might prevent the harmful clumping of proteins linked to Parkinson's and Alzheimer's diseases. The award is the first NIH Support for Research Excellence (SuRE) grant earned by a researcher at the university.

Why it matters

Protein aggregation is one of the processes scientists believe contributes to Parkinson's and Alzheimer's, so research into ways to prevent or disrupt it addresses a core question in neurodegenerative disease. The grant is an early-stage research investment, and its outcomes will take years to evaluate.

This is a funded research project rather than a completed study, so no trial results or effect sizes have been reported. The grant supports laboratory investigation of protein aggregation in the context of Parkinson's and Alzheimer's disease.

The players

National Institutes of Health

The NIH is the primary U.S. federal agency funding biomedical research, including studies of neurodegenerative diseases such as Parkinson's and Alzheimer's.

Midwestern State University Texas

Midwestern State University Texas is a public university in Wichita Falls whose researchers pursue biomedical and science projects.

The details

The project investigates plant-derived membrane protein chaperones, which are proteins that help other proteins fold correctly and could potentially prevent or disrupt the aggregation of misfolded proteins. Preliminary data contributed by 2024 graduate Isabella Makelaar and graduate student Abigail Matthew helped strengthen the grant proposal. The grant funding is also expected to purchase equipment that will give students access to research techniques not previously available at the university.

Timeline

  1. Liang established the foundation for the project during his postdoctoral work at the California Institute of Technology.

  2. The NIH grant award was reported in a news article dated November 6, 2026.

Health Landscape

Protein aggregation is a shared feature of several neurodegenerative conditions, and research into preventing it is part of the broader effort to understand disease mechanisms that current treatments do not fully address. Regional research institutions receiving federal NIH support for projects like this one contribute to the pipeline of early-stage investigation in these conditions.

Research like this is at an early stage, so it does not yet change screening, treatment, or prevention recommendations for Parkinson's or Alzheimer's. Anyone with questions about their own risk or about symptoms worth monitoring is best served by discussing them with a physician.

The takeaway

This grant supports early research into whether protein-targeting approaches could one day help address the protein clumping seen in Parkinson's and Alzheimer's. Readers with concerns about these diseases should bring them to their healthcare provider, who can advise on what is appropriate for their individual situation.

Further reading

For more context on the disease at the center of this research, explore our Alzheimer's coverage.

Live Poll

Should the federal government spend more on research into Parkinson's and Alzheimer's?